-
Real-World Assessment Process to Identify Fit-for-Purpose Data Sources to Meet Milestones for Post-Marketing Requirements (PMR), Post Authorization Safety Studies (PASS), and Health Technology Assessment (HTA) Submissions Utilizing Source Exploration...
Sep 9, 2025, 16:22 PM -
Is Greece on Track to Meet the 90% HPV Vaccine Coverage Rate Target by 2030? A Mathematical Modeling Study
Sep 9, 2025, 16:22 PM -
Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Imlifidase Idefirix® for Desensitization Treatment of Highly Sensitized Adult Kidney Transplant Patients in Ireland
Sep 9, 2025, 16:22 PM -
Characterization of a Large-Scale Real-World Data Source: Impact of Linking Closed Claims With Electronic Health Record Data
Sep 9, 2025, 16:22 PM -
Standardizing Point-of-Care mRNA-Based Gene Therapy Production in Europe: A Cost and Capacity Analysis of the Nanospresso Platform
Sep 9, 2025, 16:22 PM -
Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation
Sep 9, 2025, 16:22 PM -
Deep Brain Stimulation: A Cost-Saving Treatment Option for Extreme Treatment-Refractory Obsessive-Compulsive Disorder in the UK?
Sep 9, 2025, 16:22 PM -
Prevalence of Post-Traumatic Stress Disorder Among Ambulance Officers During the COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Evaluating the Efficacy of Artificial Intelligence Models as Suitable Screening Tools in Systematic Reviews: The Example of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure Treatment
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Children With Mucopolysaccharidosis Type III MPS III: A Retrospective Claims Database Analysis in the US
Sep 9, 2025, 16:22 PM -
Organizational Budget Impact Analysis of the Port-Delivery Platform With SUSVIMO in Age-Related Macular Degeneration (AMD) in France
Sep 9, 2025, 16:22 PM -
Clinical and Economic Characteristics of eGFR-Mutated NSCLC Patients Treated With TKIs in South Korea: A Retrospective Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis
Sep 9, 2025, 16:22 PM -
(HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)
Sep 9, 2025, 16:22 PM -
Can Generative AI Deliver Patient-Friendly Summaries? A Case Study Using NICE Guidance for Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM -
Evolution of National Price Negotiations for Pharmacy/Retail Medicines (Triparty Negotiations) in Sweden and Implications for Access
Sep 9, 2025, 16:22 PM -
AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy
Sep 9, 2025, 16:22 PM
